Viscotoxin and lectin content in foliage and fruit of Viscum album L. on the main host trees of Hyrcanian forests.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
20 06 2022
20 06 2022
Historique:
received:
11
03
2022
accepted:
08
06
2022
entrez:
20
6
2022
pubmed:
21
6
2022
medline:
23
6
2022
Statut:
epublish
Résumé
Mistletoe (Viscum album L.) is a hemiparasitic plant that absorbs water and nutrients from the host tree. Mistletoe contains two groups of cytotoxic, immunomodulatory and antitumor proteins, viscotoxins and lectins. This study evaluated the quantity and quality of viscotoxins and total lectins in the stems with leaves (foliage) and fruit of mistletoe on Parrotia persica and Carpinus betulus in September with immature green berries and in December with mature white berries. Viscum album L. plants were harvested from host species located in the Hyrcanian forests of Iran in 2019. The highest level of viscotoxins was detected in the December foliage of V. album settled on C. betulus (9.25 mg/g dry weight [DW]), and the highest content of lectins was found in the December foliage of V. album settled on P. persica (0.79 mg/g DW) and C. betulus (0.73 mg/g DW) respectively. The immature green berries of V. album from both host species contained much higher concentrations of viscotoxins and lectins than the mature white berries. Four isoforms of viscotoxins, viscotoxin A1, A2, A3 and B could be identified in all samples of both host species. Viscotoxin A3 was the predominant viscotoxin isoform followed by viscotoxin A1.
Identifiants
pubmed: 35725801
doi: 10.1038/s41598-022-14504-3
pii: 10.1038/s41598-022-14504-3
pmc: PMC9209439
doi:
Substances chimiques
Lectins
0
Plant Preparations
0
Plant Proteins
0
Protein Isoforms
0
Ribosome Inactivating Proteins, Type 2
0
Toxins, Biological
0
viscotoxin
9M140C3R39
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10383Informations de copyright
© 2022. The Author(s).
Références
Anticancer Drugs. 1997 Apr;8 Suppl 1:S9-14
pubmed: 9179360
Nat Prod Res. 2016;30(4):373-85
pubmed: 25813519
Acta Crystallogr D Biol Crystallogr. 2003 Dec;59(Pt 12):2125-32
pubmed: 14646070
J Evid Based Complementary Altern Med. 2017 Oct;22(4):982-995
pubmed: 28359161
Biochem J. 1981 May 1;195(2):481-4
pubmed: 7316963
Planta Med. 1998 Oct;64(7):677-8
pubmed: 17253311
Fitoterapia. 2006 Dec;77(7-8):556-60
pubmed: 17056203
Phytother Res. 2003 May;17(5):560-2
pubmed: 12749000
Complement Med Res. 2022 Mar 24;:
pubmed: 35325897
Eur J Cancer. 2013 Dec;49(18):3788-97
pubmed: 23890767
BMC Complement Med Ther. 2020 Jul 9;20(1):215
pubmed: 32646417
Arch Pharm Res. 2020 Jun;43(6):593-629
pubmed: 32621089
BMC Complement Altern Med. 2007 May 10;7:14
pubmed: 17493268
Anticancer Drugs. 2002 Apr;13(4):373-9
pubmed: 11984083
J Ethnopharmacol. 2012 Jun 14;141(3):810-6
pubmed: 22449438
Mol Ecol. 2009 May;18(9):1946-62
pubmed: 19434811
Phytother Res. 2008 Aug;22(8):1097-103
pubmed: 18570233
J Ethnopharmacol. 2005 Apr 8;98(1-2):95-102
pubmed: 15763369
Phytomedicine. 2017 Dec 1;36:183-193
pubmed: 29157814
Pharm Biol. 2017 Dec;55(1):1-4
pubmed: 27593449
Arzneimittelforschung. 1995 Aug;45(8):905-9
pubmed: 7575759
Molecules. 2020 May 31;25(11):
pubmed: 32486427
J Food Biochem. 2020 Sep;44(9):e13377
pubmed: 32713043
Clin Exp Immunol. 2004 Aug;137(2):272-8
pubmed: 15270843
BMC Complement Med Ther. 2020 Jul 20;20(1):227
pubmed: 32690087
Arzneimittelforschung. 2006 Jun;56(6A):428-34
pubmed: 16927522
Complement Med Res. 2020;27(4):260-271
pubmed: 31927541
J Ethnobiol Ethnomed. 2020 Jul 2;16(1):40
pubmed: 32616044
Evid Based Complement Alternat Med. 2005 Mar;2(1):59-67
pubmed: 15841279